tiprankstipranks
Tonix Pharmaceuticals (TNXP)
NASDAQ:TNXP
US Market
TNXP
Tonix Pharma
RESEARCH TOOLSreports
Want to see TNXP full AI Analyst Report?

Tonix Pharma (TNXP) Income Statement

5,073 Followers

Tonix Pharma Income Statement

Last quarter (Q4 2025), Tonix Pharma's total revenue was $5.39M, an increase of 108.75% from the same quarter last year. In Q4, Tonix Pharma's net income was $-46.91M. See Tonix Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Mar 24Dec 22Dec 21
Total Revenue
$ 13.11M$ 10.09M$ 7.77M$ 0.00$ 0.00
Gross Profit
$ 6.47M$ 2.33M$ 3.03M$ 0.00$ 0.00
Operating Expenses
$ 132.17M$ 139.03M$ 121.41M$ 112.09M$ 92.31M
Depreciation and Amortization
$ 1.93M$ 3.42M$ 4.29M$ 1.25M$ 50.00K
EBITDA
$ -123.78M$ -74.32M$ -114.09M$ -110.84M$ -92.26M
Operating Income
$ -125.70M$ -136.70M$ -118.38M$ -112.09M$ -92.31M
Other Income/Expenses
$ 1.68M$ 6.67M$ 1.72M$ 1.87M$ 25.00K
Pretax Income
$ -124.02M$ -130.04M$ -116.66M$ -110.22M$ -92.29M
Net Income
$ -124.02M$ -130.04M$ -116.66M$ -110.22M$ -92.29M
Per Share Metrics
Basic EPS
$ -14.57$ -176.60$ -6.37K$ -811.68$ -163.97K
Diluted EPS
$ -14.57$ -176.60$ -6.37K$ -811.68$ -163.97K
Weighted Average Shares Outstanding
 8.51M 2.26M 1.83M 3.07M-
Weighted Average Shares Outstanding (Diluted)
 8.51M 2.26M 1.83M 3.07M-
Currency in USD

Tonix Pharma Earnings and Revenue History